Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166101 · ClinicalTrials.gov registry record
NIRS in Neonatal Cardiac Surgery
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 25
- Enrollment target
NCT00166101: Completed study, sponsored by Emory University.
NCT00166101 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00166101 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Due to the small size of infants and the use of bypass machines, physicians have difficulty assessing whether the infant's brain and body is getting enough oxygen during heart surgery. This study compares continuous monitoring via the NIRS (Near Infrared Spectroscopy) to the traditional methods of determining oxygen saturation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2002-08 |
| Est. Completion | 2008-08 |
What the finished NCT00166101 record still lists
NCT00166101 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00166101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00166101 about?
NCT00166101 is a clinical study titled "NIRS in Neonatal Cardiac Surgery". Due to the small size of infants and the use of bypass machines, physicians have difficulty assessing whether the infant's brain and body is getting enough oxygen during heart surgery. This study compares continuous monitoring via the NIRS (Near Infrared Spectroscopy) to the traditional methods of d...
What is the current status of trial NCT00166101?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2002-08. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00166101?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia